Oleg Nodelman $ZYME SEC Form 4 Insider Trading

Oleg Nodelman has filed a total of 0 insider trades in $ZYME since 2021. Their most recent trade was a of shares, made on . Their largest trade was a of shares, made on . We estimate that they now own 15.7 million shares of $ZYME, worth an estimated $407.5 million.

Insider Trading at $ZYME

There have been a total of 74 insider trades reported at $ZYME since 2021, with 9.1 million shares purchased and 387,570 shares sold. The most active insider traders in $ZYME stock have been Kenneth Galbraith, Paul Andrew Moore, and Christopher Astle. The most recent trade was a sale of 6,120 shares reported by Mark Hollywood (EVP & Chief Operating Officer), made on Jan 12, 2026.

$ZYME Executives and Stock Owners with Insider Trades

• Kenneth Galbraith, Chair & CEO

• Paul Andrew Moore, Chief Scientific Officer

• Christopher Astle, SVP & Chief Financial Officer

• Neil Josephson, Chief Medical Officer

• Ali Tehrani, Chief Executive Officer

• Jeffrey T L Smith, EVP & Chief Medical Officer

• Mark Hollywood, EVP & Chief Operating Officer

• Neil A Klompas, Chief Operating Officer

• Neil A Klompas, President & COO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.